TickerFacts.

A business in context

EYPT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-20 · 0001429932-26-000010

  2. 4 · Ownership change

    Report date 2026-08-18 · 0001530968-26-000004

  3. 8-K · Current report

    Report date 2026-08-17 · 0001193125-26-353308 · Items 8.01,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-335037

  5. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-333821 · Items 2.02,9.01

  6. 8-K · Current report

    Report date 2026-07-30 · 0001193125-26-324866 · Items 8.01,9.01

  7. 8-K · Current report

    Report date 2026-07-13 · 0001193125-26-307792 · Items 1.01,9.01

  8. 4 · Ownership change

    Report date 2026-07-10 · 0001630864-26-000010

  9. 4 · Ownership change

    Report date 2026-06-30 · 0002013623-26-000012

  10. 8-K · Current report

    Report date 2026-06-18 · 0001193125-26-276688 · Items 5.02,5.07,9.01

  11. 4 · Ownership change

    Report date 2026-05-25 · 0001429932-26-000008

  12. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-222750 · Items 8.01,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211870

  14. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-207537 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001193125-26-182035

  16. 4 · Ownership change

    Report date 2026-04-17 · 0002013623-26-000010

  17. 8-K · Current report

    Report date 2026-04-13 · 0001193125-26-152852 · Items 8.01,9.01

  18. 4 · Ownership change

    Report date 2026-03-23 · 0001630864-26-000008

  19. 8-K · Current report

    Report date 2026-03-20 · 0001193125-26-117745 · Items 7.01

  20. 4 · Ownership change

    Report date 2026-03-16 · 0001630864-26-000006

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-093917

  22. 8-K · Current report

    Report date 2026-03-04 · 0001193125-26-089856 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-084154 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2026-01-07 · 0001193125-26-005418 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-12-08 · 0001193125-25-310731 · Items 5.03,9.01

  26. 8-K · Current report

    Report date 2025-11-19 · 0001193125-25-286961 · Items 8.01,9.01

  27. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-270145 · Items 8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269471

  29. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-265706 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-10-14 · 0001193125-25-241639 · Items 1.01,8.01,9.01

  31. 8-K · Current report

    Report date 2025-10-14 · 0001193125-25-239008 · Items 2.02,8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-175418

  33. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-103527 · Items 2.02,9.01

  34. 8-K/A · Current report

    Report date 2025-07-29 · 0000950170-25-099413 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-07-29 · 0000950170-25-099383 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2025-06-18 · 0000950170-25-088169 · Items 5.02,5.07,9.01

  37. 8-K · Current report

    Report date 2025-05-27 · 0000950170-25-077373 · Items 8.01,9.01

  38. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066907

  39. 8-K · Current report

    Report date 2025-05-07 · 0000950170-25-064983 · Items 2.02,8.01,9.01

  40. DEF 14A · Proxy statement

    Report date 2025-06-18 · 0000950170-25-059290

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 0 transaction rows0AExercise / conversion: 4 transaction rows4MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

6 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-25
2026-05-27
Elston GeorgeM · Exercise / conversion
Acquired
Common Stock7500.00.0
2026-05-25
2026-05-27
Elston GeorgeF · Tax / exercise payment
Disposed
Common Stock3627.012.93
2026-05-25
2026-05-27
Elston GeorgeM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
7500.00.0
2026-04-17
2026-04-20
Ribeiro RamiroS · Sale
Disposed
Common Stock2437.015.0
2026-04-17
2026-04-20
Ribeiro RamiroM · Exercise / conversion
Acquired
Common Stock2437.08.26
2026-04-17
2026-04-20
Ribeiro RamiroM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2437.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001314102EyePoint, Inc.
pSivida

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300QE1RU34T50MR69
GLEIF legal name
EYEPOINT, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-12-19T16:18:01Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • EyePoint Pharmaceuticals · alias · wikidata
  • pSivida Corp. · alias · wikidata
  • pSivida · subsidiary · wikidata
  • EyePoint Pharmaceuticals (United Kingdom) · subsidiary · wikidata
  • EyePoint Pharmaceuticals, Inc. · former SEC name · 2018-04-02 to 2025-12-08
  • pSivida Corp. · former SEC name · 2008-06-19 to 2018-03-30
  • pSivida LTD · former SEC name · 2005-01-20 to 2008-06-18
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$43.27M$46.06M
2023-12-31$46.02M$50.43M
2022-12-31$41.40M$47.23M
2021-12-31$36.94M$45.51M
2020-12-31$34.44M$44.43M
2019-12-31$20.36M$26.60M
2018-12-31$4.57M$6.08M
2018-06-30$2.96M$3.99M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗